<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>识林 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-14T07:07:51+08:00</updated>
  <subtitle>服务于制药行业企业、机构及人员的知识与管理平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>企业元素杂质风险评估有所改善，仍有进步空间</title>
    <updated>2020-11-14T06:42:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/YDgme_ld9nwKB9QoVPCGVg</id>
    <link href="https://mp.weixin.qq.com/s/YDgme_ld9nwKB9QoVPCGVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美参议员要求 FDA 提供疫情期间国外药品检查状况与恢复计划</title>
    <updated>2020-11-13T06:43:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/FacALNGt7poKQepfUX7eIQ</id>
    <link href="https://mp.weixin.qq.com/s/FacALNGt7poKQepfUX7eIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 处方药收费新一轮谈判关注生产检查和人为因素方案等问题</title>
    <updated>2020-11-13T06:43:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/K37F7R6feXIBfIExK6RdHA</id>
    <link href="https://mp.weixin.qq.com/s/K37F7R6feXIBfIExK6RdHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来新冠治疗性抗体获紧急授权，GMP 合规要求为授权条件之一</title>
    <updated>2020-11-12T06:38:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/5461P-VHoy58l5Rj0nfTKQ</id>
    <link href="https://mp.weixin.qq.com/s/5461P-VHoy58l5Rj0nfTKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧洲众协会对欧盟无菌 GMP 附录修订提出更多改进</title>
    <updated>2020-11-12T06:38:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/cvN5awQjdKz400KIYYcpJw</id>
    <link href="https://mp.weixin.qq.com/s/cvN5awQjdKz400KIYYcpJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 相关负责人在仿制药会上小结 2020 年工作</title>
    <updated>2020-11-11T06:36:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/tum0VnU8fVquCY-qG_Mxxg</id>
    <link href="https://mp.weixin.qq.com/s/tum0VnU8fVquCY-qG_Mxxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 定稿指南为增强临床试验人群多样性提供建议</title>
    <updated>2020-11-11T06:36:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/Aj_MvRHwlzRcEt2Vm6CXEw</id>
    <link href="https://mp.weixin.qq.com/s/Aj_MvRHwlzRcEt2Vm6CXEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>WHO 发布试验用药品 GMP 指南修订草案</title>
    <updated>2020-11-10T06:40:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/qb4MYWyti0CdyWhj9Ms8Bw</id>
    <link href="https://mp.weixin.qq.com/s/qb4MYWyti0CdyWhj9Ms8Bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞新冠疫苗III期期中分析显示90%保护力，后续可期待些什么？</title>
    <updated>2020-11-10T06:40:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/hJET1HSVxOvGCBbFaJQ2CA</id>
    <link href="https://mp.weixin.qq.com/s/hJET1HSVxOvGCBbFaJQ2CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周回顾：阿尔茨海默症新药FDA专家会，WHO试验用药品GMP指南草案，GHD中长效生长激素研究现状分析，药审中心中药均一化指南</title>
    <updated>2020-11-09T06:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/XT4fpN61ih5gqf9MreZxvw</id>
    <link href="https://mp.weixin.qq.com/s/XT4fpN61ih5gqf9MreZxvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 计划发布 CAR-T 治疗产品制造指南</title>
    <updated>2020-11-09T06:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/BEpHpclc7Rec3gaR8ol4oA</id>
    <link href="https://mp.weixin.qq.com/s/BEpHpclc7Rec3gaR8ol4oA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【周末杂谈】从FDA专家会，想我国药业发展</title>
    <updated>2020-11-08T06:36:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/exQaAq_-K0jms3Vzya-7iA</id>
    <link href="https://mp.weixin.qq.com/s/exQaAq_-K0jms3Vzya-7iA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【快讯】阿尔茨海默药被 FDA 专家会彻底否决</title>
    <updated>2020-11-07T06:39:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/RSLt15XJCPZF3JkgrcEhOQ</id>
    <link href="https://mp.weixin.qq.com/s/RSLt15XJCPZF3JkgrcEhOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 开始审查加速审批路径，关注确证性试验和迅速撤市问题</title>
    <updated>2020-11-06T06:36:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/k4D_SWpuVv3m2c3plsgTbA</id>
    <link href="https://mp.weixin.qq.com/s/k4D_SWpuVv3m2c3plsgTbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧洲药品管理局将不会为新冠候选疫苗设定最低保护效力标准</title>
    <updated>2020-11-06T06:36:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/mw2e-b3DZ7J5Z8diXSpx-Q</id>
    <link href="https://mp.weixin.qq.com/s/mw2e-b3DZ7J5Z8diXSpx-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 正在制定交互式远程视频 GMP 评估指南</title>
    <updated>2020-11-05T06:33:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/G0j2X26F-XMyrftdEfDqHQ</id>
    <link href="https://mp.weixin.qq.com/s/G0j2X26F-XMyrftdEfDqHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【专题课】中国药物警戒制度与企业发展 - 日程更新</title>
    <updated>2020-11-05T06:33:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/xeTAqe2tyHfAqlBdTR2vwA</id>
    <link href="https://mp.weixin.qq.com/s/xeTAqe2tyHfAqlBdTR2vwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>